Market capitalisation, EUR | 113,389.10 m |
EPS, EUR | - |
P/B ratio | 1.51 |
P/E ratio | 21.20 |
Dividend yield | 2.79% |
Revenue, EUR | 43,070.60 m |
Net income, EUR | 5,400.07 m |
Profit margin | 12.54% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.61% | Equity United States Dividend | 160 | 0.70% | 18 | +10.18% | A2PZMV | IE00BKVKW020 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.44% | Equity United States Health Care Biotech | 224 | 0.35% | 42 | +10.99% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 1.44% | Equity United States Health Care Biotech | 224 | 0.35% | 443 | +10.99% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 1.01% | Equity United States Technology | 104 | 0.25% | 43 | +19.25% | A2QPVX | IE00BMD8KP97 |